Because certain groups at high risk for HIV/AIDS (human immunodeficiency virus/acquired
immunodeficiency syndrome) come together in correctional facilities, seroprevalence was …

… Populations involved with the criminal justice system have an increased prevalence of
infectious diseases such as HIV and hepatitis C virus (HCV) infections and tuberculosis. …

The life expectancy of persons cycling through the prison system is unknown. The authors
sought to determine the 15.5-year survival of 23,510 persons imprisoned in the state of …

Background: The prevalence of hepatitis C virus (HCV) in US prisoners is high; however,
HCV testing and treatment are rare. Infected inmates released back into society contribute to …

In the United States, 10 million inmates are released every year, and human immunodeficiency
virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) prevalence is …

Retention in care is key to effective HIV treatment, but half of PLWHA in the US are continuously
engaged in care. Incarcerated individuals are an especially challenging population to …

Collaborations among HIV clinicians, criminal justice personnel, and public health practitioners
represent an important strategy for turning the tide on the HIV epidemic. Success will …

Objectives. Although the hepatitis C epidemic in the United States disproportionately affects
correctional populations, the last national estimates of seroprevalence and disease burden …

Background: Approximately 1 in 4 of the nearly 2 million individuals in state and federal
correctional facilities are infected with hepatitis C virus (HCV). Currently, there are few reports of …

HIV-infected persons entering the criminal justice system (CJS) often experience suboptimal
healthcare system engagement and social instability, including homelessness. We …